This brand name is authorized in Poland
The drug RECTANAL contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Sodium dihydrogen phosphate monohydrate
UNII 3980JIH2SW - SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
|
|
|
|
2
Disodium phosphate dodecahydrate
UNII E1W4N241FO - SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE
|
|
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100109604 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
